Mevalonate modulation of cell proliferation and apoptosis

Oncology Reports

Volumn 4, Issue 1 SUPPL., 1997, Pages 257-261

  Baetta, Roberta ^a   Paoletti, Rodolfo ^a   Fumagalli, Remo ^a   Soma, Maurizio R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Apoptosis; BCNU; Cell cycle; Glioma; Mevalonate; Simvastatin

Indexed keywords

CARMUSTINE; SIMVASTATIN;

APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG POTENTIATION; GLIOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0031033680     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Goldstein JL and Brown MS: Regulation of the mevalonate pathway. Nature 343: 425-430, 1990.
2. Faust JR, Goldstein JL and Brown MS: Synthesis of ubiquinone and cholesterol in human fibroblast: regulation of branched pathway. Arch Biochem Biophys 192: 86-99, 1979.
3. Quesney-Huneeus V, Wiley MH and Siperstein MD: Essential role for mevalonate synthesis in DNA replication. Proc Natl Acad Sci USA 76: 5056-5060, 1979.
4. Habenicht AJR, Glomset JA and Ross R: Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J Biol Chem 255: 5134-5140, 1980.
5. Schmidt RA, Schneider CJ and Glomset JA: Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins. J Biol Chem 259: 10175-10180, 1984.
6. Maltese WA and Sheridan KM: Isoprenoid synthesis during the cell cycle. Studies of 3-hydroxy-3-methylglutaryl-coenzyme A synthase and reductase and isoprenoid labeling in cells synchronized by centrifugal elutriation. J Biol Chem 263: 10104-10110, 1988.
7. Schmidt RA, Glomset JA, Wight TN, Habenicht AJR and Ross R: A study of the influence of mevalonic acid and its metabolites on the morphology of Swiss 3T3 cells. J Cell Biol 95: 144-153, 1982.
8. Maltese WA and Sheridan KM: Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neunte outgrowth and acetylcolinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis. J Cell Physiol 125: 540-558, 1985.
9. Li G, Regazzi R, Roche E and Wollheim CB: Blockade of mevalonate production by lovastatin attenuates bombesin and vasopressin potentiation of nutrient-induced insulin secretion in HIT-T15 cells. Probable involvement of small GTP-binding proteins. Biochem J 289: 379-385, 1993.
10. Bifulco M, Laezza C, Aloj SM and Garbi C: Mevalonate controls cytoskeleton organization and cell morphology in thyroid epithelial cells. J Cell Physiol 155: 340-348, 1993.
11. Maltese WA, Defendini R, Green RA, Sheridan KM and Donley DK: Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase. J Clin Invest 76: 1748-1754, 1985.
12. Soma MR, Pagliarini P, Butti G, Paoletti R, Paoletti P and Fumagalli R: Simvastatin, an inhibitor of cholesterol biosynthesis, shows synergistic effect with [N,N-Bis(2-chloroethyl)-N-nitrosourea] and β interferon on human glioma cells. Cancer Res 52: 4348-4355, 1992.
13. Soma MR, Baetta R, de Renzis MR, Mazzini G, Davegna C, Magrassi L, Butti G, Pezzotta S, Paoletti R and Fumagalli R: In vivo enhanced antitumor activity of carmustine [N.N'-Bis(2-chloroethyl)-N-nitrosourea] by simvastatin. Cancer Res 55: 597-602, 1995.
14. Corsini A, Mazzotti M, Raiteri M, Soma MR, Gabbiani G, Fumagalli R and Paoletti R: Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis 101: 117-125, 1993.
15. Soma MR, Donetti E, Parolini C, Mazzini G, Ferrari C, Fumagalli R and Paoletti R: HMG-CoA reductase inhibitors: in vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arterioscler Thromb 13: 571-578, 1993.
16. Kaye AH and Laidlaw JD: Chemotherapy of gliomas. Curr Opin Lipidol 5: 526-533, 1992.
17. Paoletti P, Butti G, Knerich R, Gaetani P and Assietti R: Chemothereapy for malignant gliomas of the brain: a review of ten-years experience. Acta Neurochir 103: 38-46, 1990.
18. Eastman A: Activaction of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2: 275-280, 1990.